H.R. 5334 · 112th Congress

To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.

Stage
In committee
Sponsor
Brian Bilbray
Introduced
2012-05-07
Latest action
2012-05-11 · Referred to the Subcommittee on Health.

Action history

  1. 2012-05-11Referred to the Subcommittee on Health.
  2. 2012-05-07Introduced in House
  3. 2012-05-07Referred to the House Committee on Energy and Commerce.